A-431 cells and human keratinocytes synthesize and secrete the third component of complement - PubMed (original) (raw)
A-431 cells and human keratinocytes synthesize and secrete the third component of complement
N Basset-Séguin et al. J Invest Dermatol. 1990 Dec.
Free article
Abstract
Biosynthetic radiolabeling studies demonstrate that A-431 cells, a human epidermoid carcinoma cell line, and human keratinocytes synthesize and secrete C3 as two disulfide-linked polypeptide chains of 120 and 75 kD. Moreover, epithelial cell-derived C3 co-migrates in SDS-PAGE with that produced by HepG2 cells, a human hepatoma cell line previously used to elucidate complement component biosynthesis. Pulse-chase studies in A-431 cells demonstrate that epithelial cell-derived C3 is produced as a 195-kD precursor molecule, pro-C3, which is processed intracellularly by limited proteolysis into 120- and 75-kD C3 alpha and beta chains. Comparative studies demonstrate that A-431 cell-derived C3 is synthesized, processed, and secreted in parallel but in lower quantity than that produced by HepG2 cells. Treatment of biosynthetically labeled A-431 cell culture supernatants with normal human serum and zymosan produces C3 alpha chain cleavage and specific C3 fragments that are not present in control culture supernatants treated with heat-inactivated human serum and zymosan. Northern blot analysis of total cellular RNA extracted from A-431 cells, human keratinocytes, and HepG2 cells reveals quantitative identity of a 5.1-kb C3 mRNA species in these three cell types. Epithelial cell-derived C3 may play an important role in local inflammatory and immunologic reactions including such reactions in human skin. Moreover, epithelial cell C3 synthesis may have direct relevance to the recent demonstration of C3d,g within selected normal primate epithelial basement membranes, including epidermal basement membrane.
Similar articles
- Human keratinocytes and A-431 cells synthesize and secrete factor B, the major zymogen protease of the alternative complement pathway.
Yancey KB, Overholser O, Domloge-Hultsch N, Li LJ, Caughman SW, Bisalbutra P. Yancey KB, et al. J Invest Dermatol. 1992 Mar;98(3):379-83. doi: 10.1111/1523-1747.ep12499812. J Invest Dermatol. 1992. PMID: 1545147 - Studies of C3d,g in normal human epidermal basement membrane.
Yancey KB, Basset-Séguin N. Yancey KB, et al. J Invest Dermatol. 1990 Jun;94(6 Suppl):122S-127S. doi: 10.1111/1523-1747.ep12876085. J Invest Dermatol. 1990. PMID: 2191048 Review. - C3d,g deposits in inflammatory skin diseases: use of psoriatic skin as a model of cutaneous inflammation.
Basset-Séguin N, Porneuf M, Dereure O, Mils V, Tesnières A, Yancey KB, Guilhou JJ. Basset-Séguin N, et al. J Invest Dermatol. 1993 Dec;101(6):827-31. doi: 10.1111/1523-1747.ep12371702. J Invest Dermatol. 1993. PMID: 8245511 - Human glomerular epithelial cells synthesize and secrete the third component of complement.
Moutabarrik A, Nakanishi I, Matsumoto M, Zaid D, Seya T. Moutabarrik A, et al. Nephron. 1995;70(1):55-61. doi: 10.1159/000188544. Nephron. 1995. PMID: 7542367 - [Cleavage fragments of C3 and of dermo-epidermal junction of normal human skin].
Basset-Séguin N, Yancey KB. Basset-Séguin N, et al. Ann Dermatol Venereol. 1992;119(9):629-34. Ann Dermatol Venereol. 1992. PMID: 1285586 Review. French.
Cited by
- Complement C3 gene expression and regulation in human glomerular epithelial cells.
Sacks SH, Zhou W, Pani A, Campbell RD, Martin J. Sacks SH, et al. Immunology. 1993 Jul;79(3):348-54. Immunology. 1993. PMID: 8406564 Free PMC article. - Allograft rejection: effect of local synthesis of complement.
Sacks SH, Zhou W. Sacks SH, et al. Springer Semin Immunopathol. 2005 Nov;27(3):332-44. doi: 10.1007/s00281-005-0005-0. Epub 2005 Nov 11. Springer Semin Immunopathol. 2005. PMID: 16189650 Review. - C3 synthesis by A549 alveolar epithelial cells is increased by interferon-gamma and dexamethasone.
Hill LD, Sun L, Leuschen MP, Zach TL. Hill LD, et al. Immunology. 1993 Jun;79(2):236-40. Immunology. 1993. PMID: 8344703 Free PMC article. - Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation.
Darling TN, Yee C, Bauer JW, Hintner H, Yancey KB. Darling TN, et al. J Clin Invest. 1999 May 15;103(10):1371-7. doi: 10.1172/JCI4338. J Clin Invest. 1999. PMID: 10330419 Free PMC article. - Complement system in dermatological diseases - fire under the skin.
Panelius J, Meri S. Panelius J, et al. Front Med (Lausanne). 2015 Jan 29;2:3. doi: 10.3389/fmed.2015.00003. eCollection 2015. Front Med (Lausanne). 2015. PMID: 25688346 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous